retatrutide clinical trials south africa trial Eli Lilly infiltrates anti-obesity market as Phase III for begins Experts to reveal results of – retatrutide clinical trials status 2025

Clinical Nutrition ESPEN, 37 , 9-23

For tailored advice on managing your health as you transition off a GLP-1 medication, consider scheduling an appointment with a Kroger Health registered dietitian, our nutrition experts

And even if people manage to maintain the eating habits they developed while on Ozempic, their blood sugar might still rise when they stop treatment, because the drug boosts the production of insulin, a hormone involved in blood sugar control

This broader targeting allows retatrutide to potentially offer greater weight loss and metabolic benefits

In a randomised controlled trial with over 1800 participants comparing tirzepatide to semaglutide, the tirzepatide group reported more serious adverse events (5-7% VS 3%) and higher discontinuation rates due to adverse events (6-8.5% VS 4%)